Joanne Wuensch
Stock Analyst at Citigroup
(4.50)
# 231
Out of 4,840 analysts
384
Total ratings
65.64%
Success rate
12.34%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Maintains: Neutral | $20 → $24 | $21.48 | +11.73% | 15 | May 22, 2025 | |
| SYK Stryker | Maintains: Buy | $443 → $455 | $383.78 | +18.56% | 14 | May 22, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $3.2 → $3.6 | $3.43 | +4.96% | 11 | May 22, 2025 | |
| LUNG Pulmonx | Maintains: Neutral | $6.5 → $4.15 | $3.09 | +34.52% | 11 | May 22, 2025 | |
| IRTC iRhythm Technologies | Maintains: Buy | $130 → $167 | $146.37 | +14.09% | 18 | May 22, 2025 | |
| ISRG Intuitive Surgical | Maintains: Buy | $590 → $650 | $550.19 | +18.14% | 17 | May 22, 2025 | |
| PODD Insulet | Maintains: Buy | $320 → $380 | $326.64 | +16.34% | 15 | May 22, 2025 | |
| EW Edwards Lifesciences | Maintains: Buy | $84 → $95 | $76.22 | +24.64% | 20 | May 22, 2025 | |
| DXCM DexCom | Maintains: Buy | $82 → $102 | $85.33 | +19.54% | 14 | May 22, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $119 → $125 | $106.17 | +17.74% | 35 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $133 → $140 | $121.63 | +15.10% | 5 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $13 | $11.80 | +10.17% | 5 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $105 → $86 | $71.01 | +21.11% | 4 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $110 | $80.59 | +36.49% | 20 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $160 | $132.94 | +20.36% | 20 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $92 → $107 | $81.18 | +31.81% | 19 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $200 → $245 | $272.63 | -10.13% | 24 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $175 | $153.25 | +14.19% | 12 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $37 → $35 | $30.87 | +13.38% | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $132 → $162 | $96.97 | +67.06% | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $16 → $22 | $13.12 | +67.68% | 14 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $45 → $50 | $36.88 | +35.57% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $94 → $85 | $67.99 | +25.02% | 7 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $134 → $120 | $94.21 | +27.38% | 22 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $220 → $250 | $174.51 | +43.26% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $69 | $86.70 | -20.42% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $109 → $127 | $246.22 | -48.42% | 6 | Dec 10, 2018 |
Tandem Diabetes Care
May 22, 2025
Maintains: Neutral
Price Target: $20 → $24
Current: $21.48
Upside: +11.73%
Stryker
May 22, 2025
Maintains: Buy
Price Target: $443 → $455
Current: $383.78
Upside: +18.56%
Sight Sciences
May 22, 2025
Maintains: Neutral
Price Target: $3.2 → $3.6
Current: $3.43
Upside: +4.96%
Pulmonx
May 22, 2025
Maintains: Neutral
Price Target: $6.5 → $4.15
Current: $3.09
Upside: +34.52%
iRhythm Technologies
May 22, 2025
Maintains: Buy
Price Target: $130 → $167
Current: $146.37
Upside: +14.09%
Intuitive Surgical
May 22, 2025
Maintains: Buy
Price Target: $590 → $650
Current: $550.19
Upside: +18.14%
Insulet
May 22, 2025
Maintains: Buy
Price Target: $320 → $380
Current: $326.64
Upside: +16.34%
Edwards Lifesciences
May 22, 2025
Maintains: Buy
Price Target: $84 → $95
Current: $76.22
Upside: +24.64%
DexCom
May 22, 2025
Maintains: Buy
Price Target: $82 → $102
Current: $85.33
Upside: +19.54%
Boston Scientific
May 22, 2025
Maintains: Buy
Price Target: $119 → $125
Current: $106.17
Upside: +17.74%
May 22, 2025
Upgrades: Buy
Price Target: $133 → $140
Current: $121.63
Upside: +15.10%
May 1, 2025
Maintains: Neutral
Price Target: $14 → $13
Current: $11.80
Upside: +10.17%
Apr 30, 2025
Maintains: Buy
Price Target: $105 → $86
Current: $71.01
Upside: +21.11%
Mar 7, 2025
Maintains: Buy
Price Target: $115 → $110
Current: $80.59
Upside: +36.49%
Mar 4, 2025
Maintains: Buy
Price Target: $135 → $160
Current: $132.94
Upside: +20.36%
Mar 4, 2025
Upgrades: Buy
Price Target: $92 → $107
Current: $81.18
Upside: +31.81%
Dec 11, 2024
Maintains: Neutral
Price Target: $200 → $245
Current: $272.63
Upside: -10.13%
Dec 11, 2024
Maintains: Buy
Price Target: $185 → $175
Current: $153.25
Upside: +14.19%
Dec 11, 2024
Maintains: Neutral
Price Target: $37 → $35
Current: $30.87
Upside: +13.38%
Dec 11, 2024
Upgrades: Buy
Price Target: $132 → $162
Current: $96.97
Upside: +67.06%
Nov 5, 2024
Maintains: Sell
Price Target: $16 → $22
Current: $13.12
Upside: +67.68%
Oct 1, 2024
Maintains: Neutral
Price Target: $45 → $50
Current: $36.88
Upside: +35.57%
Aug 22, 2024
Maintains: Neutral
Price Target: $94 → $85
Current: $67.99
Upside: +25.02%
Jul 10, 2024
Maintains: Neutral
Price Target: $134 → $120
Current: $94.21
Upside: +27.38%
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $174.51
Upside: +43.26%
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $86.70
Upside: -20.42%
Dec 10, 2018
Upgrades: Outperform
Price Target: $109 → $127
Current: $246.22
Upside: -48.42%